Abigail M. Freeman

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Tom P. Freeman, Chandni Hindocha, Gianluca Baio et al. · The Lancet Psychiatry · 2020 · 192 citations · Full text

Adaptive Bayesian Trial, Cannabis Use, Psychoactive Drug +14

Fetal-Derived Trophoblast Use the Apoptotic Cytokine Tumor Necrosis Factor-α–Related Apoptosis-Inducing Ligand to Induce Smooth Muscle Cell Death

Rosemary J. Keogh, Lynda K. Harris, Abigail M. Freeman et al. · Circulation Research · 2007 · 114 citations · Full text

Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity

Matthew B. Wall, Rebecca Pope, Tom P. Freeman et al. · Journal of Psychopharmacology · 2019 · 82 citations

Open dialogue in the UK: qualitative study

Rachel Tribe, Abigail M. Freeman, Steven R. Livingstone et al. · BJPsych Open · 2019 · 78 citations · Full text

A double blind, multicentre, placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and knee.

H Berry, H. A. Bird, Cheryl A. Black et al. · Annals of the Rheumatic Diseases · 1992 · 44 citations · Full text